PDE5A and benign prostatic hyperplasia: Since the first clinical trial conducted by Sairam et al.27 in 2002 with sildenafil for treating LUTS/BPH/ED patients, many clinical trials have been performed demonstrating efficacy and safety of PDE5-Is for treating LUTS/BPH.